Patents by Inventor Matthew M. RANKIN

Matthew M. RANKIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230322888
    Abstract: Provided herein are GLP1-GDF15 fusion proteins comprising a GLP1 or GLP1 variant peptide, a first linker peptide, a serum albumin protein, a second linker peptide, and a GDF15 protein.
    Type: Application
    Filed: June 9, 2023
    Publication date: October 12, 2023
    Inventors: Shannon MULLICAN, Matthew M. RANKIN, Xiefan LIN-SCHMIDT, Chichi HUANG, Jennifer FURMAN, Songmao ZHENG, Shamina RANGWALA, Serena NELSON
  • Patent number: 11713345
    Abstract: Provided herein are GLP1-GDF15 fusion proteins comprising a GLP1 or GLP1 variant peptide, a first linker peptide, a serum albumin protein, a second linker peptide, and a GDF15 protein.
    Type: Grant
    Filed: October 22, 2019
    Date of Patent: August 1, 2023
    Assignee: Janssen Sciences Ireland Unlimited Company
    Inventors: Shannon Mullican, Matthew M. Rankin, Xiefan Lin-Schmidt, Chichi Huang, Jennifer Furman, Songmao Zheng, Shamina Rangwala, Serena Nelson
  • Publication number: 20220089669
    Abstract: Provided herein are GLP1-GDF15 fusion proteins comprising a GLP1 or GLP1 variant peptide, a first linker peptide, a serum albumin protein, a second linker peptide, and a GDF15 protein.
    Type: Application
    Filed: October 22, 2019
    Publication date: March 24, 2022
    Inventors: Shannon MULLICAN, Matthew M. RANKIN, Xiefan LIN-SCHMIDT, Chichi HUANG, Jennifer FURMAN, Songmao ZHENG, Shamina RANGWALA, Serena NELSON